Efficacy of Totalfill® and ProRoot MTA® as Pulpotomy Agent in Primary Molars
Status:
Completed
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
An experimental prospective double-blind, randomized clinical trial (RCT) with parallel
design. To evaluate the outcome of using 2 pulpotomy agents: Totalfill® as study group and
mineral trioxide aggregate (MTA®) as a control.